Milan, Italy

Maria B Gorini

This inventor holds 1 USPTO granted patent. Top assignee: Iketon Farmaceutici, S.r.l.. Active years: 1992.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria B Gorini: Innovator in Antithrombotic Research

Introduction

Maria B Gorini is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of supersulfated heparins. Her innovative work has garnered attention for its potential applications in antithrombotic therapies.

Latest Patents

Maria B Gorini holds a patent for a process related to supersulfated heparins. The patent, titled "A process for the depolymerization and supersulfation of heparin," discloses a method that involves treating heparin with oleum containing from 2 to 6% free sulfuric anhydride at temperatures ranging from -10°C to +20°C. The resulting supersulfated heparins exhibit molecular weights between 2000 and 5000, with a sulfation degree from 3.4 to 4.3. These compounds are noted for their remarkable antithrombotic activity, making them valuable in medical applications.

Career Highlights

Maria is associated with Iketon Farmaceutici, S.r.l., where she continues to advance her research in the pharmaceutical industry. Her work has led to the development of innovative solutions that address critical health issues related to blood coagulation.

Collaborations

Throughout her career, Maria has collaborated with notable professionals in her field, including Paolo Casati and Antonio Maggi. These partnerships have contributed to the success of her research and the advancement of her patented technologies.

Conclusion

Maria B Gorini is a trailblazer in the field of antithrombotic research, with her innovative patent on supersulfated heparins showcasing her commitment to improving medical treatments. Her contributions continue to influence the pharmaceutical landscape positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…